about
Different effects of farrerol on an OVA-induced allergic asthma and LPS-induced acute lung injuryLPS-induced lung inflammation in marmoset monkeys - an acute model for anti-inflammatory drug testingAlteration in the expression of inflammatory parameters as a result of oxidative stress produced by moderate zinc deficiency in rat lungMechanistic role of a disease-associated genetic variant within the ADAM33 asthma susceptibility gene.Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatasesA computable cellular stress network model for non-diseased pulmonary and cardiovascular tissue.Clara cell 10-kDa protein gene transfection inhibits NF-κB activity in airway epithelial cells.Alterations in the expression of the NF-κB family member RelB as a novel marker of cardiovascular outcomes during acute exacerbations of chronic obstructive pulmonary disease.New drugs targeting Th2 lymphocytes in asthma.Glucocorticoid receptor and histone deacetylase-2 mediate dexamethasone-induced repression of MUC5AC gene expression.Minocycline blocks asthma-associated inflammation in part by interfering with the T cell receptor-nuclear factor κB-GATA-3-IL-4 axis without a prominent effect on poly(ADP-ribose) polymeraseQuantitative, solution-phase profiling of multiple transcription factors in parallel.Update in chronic obstructive pulmonary disease 2006.Sputum biomarkers of inflammation in cystic fibrosis lung diseaseActivating transcription factor 3 is a negative regulator of allergic pulmonary inflammationSteroid-resistant neutrophilic inflammation in a mouse model of an acute exacerbation of asthmaPost-allergen challenge inhibition of poly(ADP-ribose) polymerase harbors therapeutic potential for treatment of allergic airway inflammation.Therapeutic perspectives in bronchial vascular remodeling in COPD.Prolonged cigarette smoke exposure alters mitochondrial structure and function in airway epithelial cells.Pulmonary effects of inhaled limonene ozone reaction products in elderly rats.Pathophysiology of allergic inflammation.The importance of epigenetics in the development of chronic obstructive pulmonary disease.Role of transcription factors in the pathogenesis of asthma and COPD.Heterogeneity of transcription factor expression and regulation in human airway epithelial and smooth muscle cells.A database of annotated promoters of genes associated with common respiratory and related diseases.Bioinformatics analysis of gene expression profiling for identification of potential key genes among ischemic stroke.Comparison of in vitro toxicological effects of biomass smoke from different sources of animal dung.Cigarette smoke extract regulates cytosolic phospholipase A2 expression via NADPH oxidase/MAPKs/AP-1 and p300 in human tracheal smooth muscle cells.Poly(ADP-Ribose)Polymerase-1 in Lung Inflammatory Disorders: A Review.Cellular arrays for large-scale analysis of transcription factor activity.YB-1 binds to the MMP-13 promoter sequence and represses MMP-13 transactivation via the AP-1 site.Naringenin inhibits allergen-induced airway inflammation and airway responsiveness and inhibits NF-kappaB activity in a murine model of asthma.Efficacy of sulphasalazine on lung histopathology in a murine model of chronic asthma.PARP inhibition treatment in a nonconventional experimental mouse model of chronic asthma.Functional Analysis of the Thymic Stromal Lymphopoietin Variants in Human Bronchial Epithelial Cells
P2860
Q28482560-95F3254D-F6C5-4274-9D41-596436D9D2B2Q28482881-B89EB366-90F8-4F32-AF32-4D16A1C6BC58Q28567358-2539544F-411D-4119-BCCF-DE63274C14AAQ33291238-5661EAD8-4647-43D2-AB15-06DA5A5ADF1FQ33636430-8060AC05-3B73-41ED-9EFA-84C342FBC9BCQ34051850-44DD62AF-30B2-4E11-AFE4-1FDE0DAA7DA6Q34256973-A3AC6304-6809-472D-9FFD-564E5B8B1982Q34542055-3C8D2B14-1700-42E3-9318-67CE1DEA36CAQ36485165-D69543C3-5757-476C-B2B3-9683E31C6F99Q36539631-146A35C6-2915-450D-ADB7-075CD8B49B46Q36543658-0643B3EE-299A-4357-97DB-1D146D13A721Q36640045-37FD9B33-ABD0-4BA0-8E3A-3A0B8BE6C333Q36838782-1EB69ECB-263F-4A2B-948B-A674744C3ED3Q36891552-DAC7F29A-CB92-40F2-8F80-2C066C557DD5Q36916340-41CF7AFC-2954-49E6-A317-D59AF3976905Q37098449-1A5A010F-557E-4E39-9394-A9724E9ED4ECQ37339488-278AA177-D2A6-4864-AC5F-EC3C0639AFDAQ37362620-24332E2D-84D4-4457-8A55-3E796B6A5DCFQ37368004-DCF27AD0-EB52-4EB1-B13F-CE9044FCD9F7Q37409620-C73D7087-8CAA-4762-A45F-D55E052A4A70Q37891126-F9448A3B-7AAD-405D-B9AE-35109146F613Q37913490-24A1C36D-B685-4745-AF21-C5486F51B830Q38087650-3BC96A28-F5BE-4E88-B9E4-0D9BC13943A1Q38301015-664B0B77-977E-48A7-8E50-515E4ABB49F9Q38498148-50F4138F-DCCF-40C4-9ABC-2AC151849A74Q38611496-B17B4D4C-0A2E-4FAE-9C48-6F0854D19CB1Q38750155-1CBC47F4-16E3-4474-A290-B440063A38A9Q39602460-230F2BB9-AA65-4CEA-9652-3F2D901DC5D0Q41820940-BB1ABA5A-BAD9-44F4-BFCB-DC8B13968E03Q42574720-3E68998A-AC7C-44E1-A405-71AA66936BDBQ42628903-1BA99F27-CA51-4D10-A780-0FEC5175F425Q43268878-C7C48A87-AC54-41C8-8A88-A0BB0709375EQ46319705-91711286-0DCB-452E-8472-9E40660E5FF0Q51529685-0F6C2A6E-C4EB-4414-A65F-01B2F9C289D1Q57273027-1A4BF5D1-CA04-424D-A5E5-FD3428DA3C9B
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Transcription factors in airway diseases.
@ast
Transcription factors in airway diseases.
@en
type
label
Transcription factors in airway diseases.
@ast
Transcription factors in airway diseases.
@en
prefLabel
Transcription factors in airway diseases.
@ast
Transcription factors in airway diseases.
@en
P2860
P1476
Transcription factors in airway diseases.
@en
P2093
Peter J Barnes
P2860
P2888
P304
P356
10.1038/LABINVEST.3700456
P577
2006-07-24T00:00:00Z